Annual Cash & Cash Equivalents
$12.98 M
-$6.49 M-33.33%
December 31, 2023
Summary
- As of February 7, 2025, TMCI annual cash & cash equivalents is $12.98 million, with the most recent change of -$6.49 million (-33.33%) on December 31, 2023.
- During the last 3 years, TMCI annual cash & cash equivalents has fallen by -$5.10 million (-28.19%).
- TMCI annual cash & cash equivalents is now -87.73% below its all-time high of $105.83 million, reached on December 31, 2021.
Performance
TMCI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$12.11 M
-$6.07 M-33.39%
September 30, 2024
Summary
- As of February 7, 2025, TMCI quarterly cash and cash equivalents is $12.11 million, with the most recent change of -$6.07 million (-33.39%) on September 30, 2024.
- Over the past year, TMCI quarterly cash and cash equivalents has increased by +$4.83 million (+66.39%).
- TMCI quarterly cash and cash equivalents is now -89.88% below its all-time high of $119.62 million, reached on June 30, 2021.
Performance
TMCI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TMCI Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -33.3% | +66.4% |
3 y3 years | -28.2% | -88.1% |
5 y5 years | +6.9% | -88.1% |
TMCI Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -87.7% | at low | -88.6% | +66.4% |
5 y | 5-year | -87.7% | +6.9% | -89.9% | +66.4% |
alltime | all time | -87.7% | +6.9% | -89.9% | +66.4% |
Treace Medical Concepts Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $12.11 M(-33.4%) |
Jun 2024 | - | $18.18 M(+94.8%) |
Mar 2024 | - | $9.33 M(-28.1%) |
Dec 2023 | $12.98 M(-33.3%) | $12.98 M(+78.4%) |
Sep 2023 | - | $7.28 M(-39.5%) |
Jun 2023 | - | $12.04 M(-59.4%) |
Mar 2023 | - | $29.61 M(+52.1%) |
Dec 2022 | $19.47 M | $19.47 M(-78.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $88.55 M(-12.8%) |
Jun 2022 | - | $101.53 M(+3.1%) |
Mar 2022 | - | $98.48 M(-6.9%) |
Dec 2021 | $105.83 M(+485.4%) | $105.83 M(-3.3%) |
Sep 2021 | - | $109.46 M(-8.5%) |
Jun 2021 | - | $119.62 M(+637.6%) |
Mar 2021 | - | $16.22 M(-10.3%) |
Dec 2020 | $18.08 M(+48.9%) | $18.08 M |
Dec 2019 | $12.14 M | - |
FAQ
- What is Treace Medical Concepts annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Treace Medical Concepts?
- What is Treace Medical Concepts annual cash & cash equivalents year-on-year change?
- What is Treace Medical Concepts quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Treace Medical Concepts?
- What is Treace Medical Concepts quarterly cash and cash equivalents year-on-year change?
What is Treace Medical Concepts annual cash & cash equivalents?
The current annual cash & cash equivalents of TMCI is $12.98 M
What is the all time high annual cash & cash equivalents for Treace Medical Concepts?
Treace Medical Concepts all-time high annual cash & cash equivalents is $105.83 M
What is Treace Medical Concepts annual cash & cash equivalents year-on-year change?
Over the past year, TMCI annual cash & cash equivalents has changed by -$6.49 M (-33.33%)
What is Treace Medical Concepts quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TMCI is $12.11 M
What is the all time high quarterly cash and cash equivalents for Treace Medical Concepts?
Treace Medical Concepts all-time high quarterly cash and cash equivalents is $119.62 M
What is Treace Medical Concepts quarterly cash and cash equivalents year-on-year change?
Over the past year, TMCI quarterly cash and cash equivalents has changed by +$4.83 M (+66.39%)